Salesforce.com Inc. (NYSE: CRM) is slated to release its earnings results for the third quarter of 2020 on Tuesday, December 3, after the market closes. The results will be driven by the delivery of enterprise software through the cloud with a focus on customer relationship management.
With the development of technologies such as cloud, mobile, social, Internet of Things (IoT), and artificial intelligence, the company could remain beneficial by the growth at least in the near future.
The company depends on subscription fees from customers accessing its enterprise cloud exchange for revenue growth in the third quarter. The professional services including process mapping, project management, and implementation services could also be behind the top-line growth.
Analysts expect the company’s earnings to increase by 8.20% to $0.66 per share and revenue will jump by 31.10% to $4.45 billion for the third quarter. The company has surprised investors by beating analysts’ expectations in all of the past four quarters. The majority of the analysts recommended a “buy” rating with an average price target of $189.20.
For the second quarter, Salesforce posted a 70% dip in earnings due to higher costs and expenses despite a 22% increase in revenue. The top-line growth was driven by better performance at the subscription and support segment as well as professional services and other divisions.
For the third quarter, the company expects adjusted earnings of $0.65 to $0.66 per share and revenues in the range of $4.44 billion to $4.45 billion. For the full year 2020, adjusted earnings are anticipated to be $2.82 to $2.84 per share and revenue is predicted to be $16.75 billion to $16.90 billion.
After Novavax (NASDAQ: NVAX) reported its progress on developing the COVID-19 vaccine at the end of February, the shares of the company started trading in double-digits after a long time.
Cannabis was recognized as an essential business in several markets when the shutdown came into effect, including Canada and some US states, at a time when its legalization is getting
Eastman Kodak (NYSE: KODK) reported a loss of $5 million on revenue of $213 million in the second quarter of 2020. The company earned $201 million in the prior-year quarter.